Nadia Malagolini Selected Research

Sialyltransferases

1/2019	Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types.
1/2018	Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1.
8/2017	Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage.
9/2014	Sialosignaling: sialyltransferases as engines of self-fueling loops in cancer progression.
10/2009	ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nadia Malagolini Research Topics

Disease

19	Neoplasms (Cancer) 04/2022 - 01/2006
9	Colonic Neoplasms (Colon Cancer) 04/2021 - 02/2006
4	Colorectal Neoplasms (Colorectal Cancer) 04/2021 - 07/2007
4	Neoplasm Metastasis (Metastasis) 09/2020 - 01/2011
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 02/2009
3	Wounds and Injuries (Trauma) 11/2020 - 02/2006
2	Inflammation (Inflammations) 01/2021 - 02/2016
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2021
1	Stomach Neoplasms (Stomach Cancer) 10/2021
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2021
1	Carcinogenesis 04/2021
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2019
1	Microsatellite Instability 01/2019
1	Disease Progression 01/2019
1	Non-Muscle Invasive Bladder Neoplasms 01/2018
1	Genomic Instability 08/2017
1	Hemorrhage 01/2014
1	Infections 01/2004

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 10/2021 - 07/2007
8	CarbohydratesIBA 04/2022 - 01/2012
7	EnzymesIBA 04/2022 - 01/2006
6	Messenger RNA (mRNA)IBA 11/2020 - 01/2006
5	Complementary DNA (cDNA)IBA 11/2020 - 02/2006
5	SialyltransferasesIBA 01/2019 - 10/2009
4	GlycosyltransferasesIBA 04/2022 - 09/2014
4	Sialyl Lewis X AntigenIBA 09/2020 - 07/2007
4	Glycoproteins (Glycoprotein)IBA 02/2018 - 02/2006
3	FucosyltransferasesIBA 09/2020 - 07/2007
3	LigandsIBA 02/2018 - 01/2011
3	SugarsIBA 08/2017 - 01/2006
3	Lewis Blood Group AntigensIBA 09/2014 - 01/2012
3	Protein Isoforms (Isoforms)IBA 08/2014 - 01/2006
2	Polysaccharides (Glycans)IBA 01/2021 - 01/2019
2	Biological ProductsIBA 11/2020 - 01/2019
2	AgarIBA 11/2020 - 01/2019
2	Tumor Viral Antigens (Large T Antigen)IBA 01/2018 - 10/2009
2	lactosamineIBA 09/2014 - 01/2012
2	GangliosidesIBA 09/2014 - 01/2012
2	SelectinsIBA 08/2014 - 01/2011
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2013 - 02/2006
2	LectinsIBA 02/2009 - 01/2006
2	beta-D-Galactoside alpha 2-6-SialyltransferaseIBA 02/2006 - 01/2006
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	EpitopesIBA 04/2022
1	MicroRNAs (MicroRNA)IBA 04/2021
1	glycosylated IgGIBA 01/2021
1	haematoside synthetaseIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2019
1	matrigelIBA 01/2019
1	DisaccharidesIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 08/2017
1	Oxidants (Oxidizing Agents)IBA 08/2017
1	AcetylglucosamineIBA 02/2016
1	polysialic acidIBA 09/2014
1	Sialic AcidsIBA 09/2014
1	von Willebrand FactorIBA 01/2014
1	VitronectinIBA 04/2013
1	Small Interfering RNA (siRNA)IBA 01/2011
1	3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferaseIBA 01/2011
1	beta-Galactoside alpha-2,3-SialyltransferaseIBA 10/2009
1	beta-1,4-N-acetyl-galactosaminyl transferase 2IBA 07/2007
1	CollagenIBA 02/2006
1	Neuraminidase (Sialidase)IBA 02/2006
1	Fibronectins (Fibronectin)IBA 02/2006
1	IntegrinsIBA 02/2006
1	DNA PrimersIBA 01/2006
1	Proteins (Proteins, Gene)FDA Link 01/2004
1	UromodulinIBA 01/2004

Therapy/Procedure

2	Therapeutics 01/2019 - 08/2017
1	Immunotherapy 01/2018
1	Investigational Therapies (Experimental Therapy) 09/2014